Overview

Alcohol and other drug (AOD) treatment services assist people to address their drug use. Treatment objectives can include reduction or cessation of drug use as well as improvements to social and personal functioning. Assistance may also be provided to support the family and friends of people using drugs.

More reports and statistics on AOD treatment services can be found under Alcohol, Illicit use of drugs and Smoking.

Latest findings

Where amphetamines were reported as the principal drug of concern, 78% of episodes were for methamphetamines only There were 3,422 authorised opioid pharmacotherapy prescribers Counselling was the most common AOD treatment type, accounting for almost 2 in 5 (37%) closed treatment episodes Around 1 in 10 opioid pharmacotherapy clients identified as being Aboriginal and/or Torres Strait Islander On average, 16 opioid pharmacotherapy clients were treated by each prescriber There were 3,084 opioid pharmacotherapy dosing points The median age of opioid pharmacotherapy clients was 44 years 53,316 clients received opioid pharmacotherapy treatment nationally 2 in 3 opioid pharmacotherapy clients were male

Featured reports

See all reports

Highlights

53,316clients received opioid pharmacotherapy treatment from authorised prescribers for opioid drug dependence in 2020
There were 3,422 authorised opioid pharmacotherapy prescribers in 2020
37% of closed treatment episodes had counselling as the most common AOD treatment type
237,545 treatment episodes were provided by AOD treatment agencies in 2019–20
2 in 3opioid pharmacotherapy clients were male. The median age of opioid pharmacotherapy clients was 44
139,295 clients received AOD treatment in 2019–20
The most common drugs that led clients to seek AOD treatment were alcohol, amphetamines, cannabis and heroin
1,258 publicly-funded alcohol and other drug treatment agencies provided services to clients in 2019–20